Reduced Risk Status: |
|
IPM Compatibility: |
PER REQUESTOR: GOOD IPM FIT; IS SOFT ON BIOLOGICAL CONTROL AGENTS:05/15
|
Reasons for need: |
DOWNY MILDEW AND PHYTOPHTHORA
|
Requesting State(s): |
CA:Ingersoll, T., Sfetcu, D., Bachie, O. ; FL:Vallad, G. ; ME:Gondoza, H ; MS:Henn, A. ; NC:Quesada, L. ; TX:Bledsoe, M ; UT:Sfetcu, D ;
|
PCR Use Pattern: |
USE THE ZAMPRO PRODUCT; MAKE 2 FOLIAR AND/OR DRENCH APPLIC OF 14 FL OZ PRODUCT/A, 7-DAY INTERVAL, 0-DAY PHI; APPLY PRIOR TO DISEASE DEVELOPMENT (MFG INDICATES THE PRODUCT IS NAMED ORVEGO:04/18)
|
EPA Default Residue Trials: |
ANY 4 TRIALS
|
IR-4 Residue Trial Plan: |
ANY 4 TRIALS
|
Residue Protocol Use Pattern: |
|
Efficacy/Crop Safety (E/CS) Data Required: |
NO EFFICACY TRIALS NEEDED, BUT 2 CROP SAFETY TRIALS NEEDED (1X AND 2X) ON PROMINENT GH COMMERCIAL VARIETIES (NEED TO EXAMINE IF 4 CANADIAN E/CS TRIALS ARE SUFFICIENT):08/16; MFG COMPLETING E/CS DATA BY JUNE 2018:04/18
|
E/CS Research Comments: |
MFG REQUESTS THAT CERTAIN E/CS TESTING STANDARDS BE MET IN E/CS RESEARCH TO SUPPORT PRODUCT COMMERCIALIZATION; NEED SUFFICIENT DATASET TO SECURE CA REGISTRATION, FOR THE ORVEGO FUNGICIDE FORMULATION:08/15
|
Label Use Pattern Submitted To EPA: |
|
EPA PIF Status: |
Green 2015;
|
EPA Status: |
PEND:07/17
|
EPA PRIA Date: |
|
MRID: |
|
Comments: |
KEY EXPORT MARKET IS CANADA; THERE ARE TOLERANCES FOR BOTH AIS, BUT THE ZAMPRO LABEL STATES NOT FOR GH OR TRANSPLANT PRODUCTION; NEED ROTATIONAL PRODUCTS FOR RESISTANCE MANAGEMENT:05/15; MFG SUPPORTS USE FOR ORVEGO FUNGICIDE FORMULATION FOR BOTH GH PRODUCTION AND CONSUMER TRANSPLANTS:08/15; CANADA HAS COMPLETE RESIDUE STUDY:05/16; PMC SUBMITTED TO PMRA:12/16; DRAFT IR-4 PETITION SENT TO BASF:03/17; IR-4 PREPARED COVER FOR DIMETHOMORPH FOR CANADIAN FINAL REPORT TO SUBMIT TO EPA:07/17; THIS USE WAS APPROVED BY PMRA IN CANADA, SO EPA CAN USE THE DER FROM PMRA:04/18
|
International Status: |
|
Archive Location: |
002685 (includes Canadian Final Reports)
|
QA Archive: |
|